BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 24, 2011
View Archived Issues
PSMA-ADC appears safe in first-in-human study in taxane-refractory metastatic CRPC
Read More
Interim phase I data support safety of tremelimumab plus bicalutamide in recurrent prostate cancer
Read More
Intraprostatic administration of PROSTVAC VF cancer vaccine is feasible and safe
Read More
Zymes receives Michael J. Fox Foundation grant to assess WS-CoQ10 for Parkinson's disease
Read More
Tariquidar is safe in combination with docetaxel in patients with cancer
Read More
Shire reviews progress of fourth quarter 2010
Read More
Multistage tuberculosis vaccine H-56 combats late-stage infection in vivo
Read More
Vical and U.S. government extend collaboration to develop vaccines against emerging diseases
Read More
Eisai's warfarin potassium tablets approved in Japan for pediatric use
Read More
Novel tyrosine-protein kinase SYK inhibitors described by IRM
Read More
Laboratorios Salvat presents novel APAF-1 inhibitors
Read More
Dainippon Sumitomo Pharma reports on third quarter fiscal 2010
Read More
Roche presents novel P2X7 receptor modulators
Read More
Sun Pharma and Caraco enter merger agreement
Read More
Proacta and Yakult Honsha enter PR-509 development agreement
Read More
Nesina approved in Japan for additional indications in type 2 diabetes
Read More
New HSL inhibitors claimed
Read More
Stamford Hospital participates in FDA's Expanded Access program for Generex Oral-lyn
Read More
Elan and PPD form global drug development collaboration
Read More
Phase III Heplisav trials cleared by safety monitoring board to continue
Read More
Argon Pharma discovers new prostaglandin G/H synthase 2 inhibitors
Read More
Delcath Systems receives FDA refusal to file letter for chemosaturation system
Read More
Tranzyme Pharma and Norgine start phase III trial of ulimorelin for postoperative ileus
Read More
Japanese approval granted for Sosei's NorLevo emergency contraceptive pill
Read More
FDA grants fast track status to Sunesis' Vosaroxin in AML
Read More